Recent advances in Alzheimer disease genetics
1Univ Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, Department of Genetics and CNRMAJ, F-76000 Rouen, France.
Current Opinion in Neurology
|January 18, 2024
Summary
Recent genetic studies reveal new Alzheimer disease (AD) risk factors. Advances in large-scale genetic analysis enhance understanding of AD etiology and potential prevention strategies.
Area of Science:
- Genetics and genomics
- Neurodegenerative disease research
- Alzheimer disease (AD) etiology
Background:
- Genetics studies are crucial for understanding Alzheimer disease (AD) mechanisms.
- Recent technological advancements and larger study cohorts have accelerated progress.
Approach:
- Investigated monogenic AD, focusing on pathogenic variants and presymptomatic individuals.
- Analyzed large-scale genome-wide association studies (GWAS) and exome/genome sequencing data for complex AD.
- Explored common and rare genetic risk factors and their combined effects.
Key Points:
- Identified novel common and rare risk factors for complex AD through large-scale genetic studies.
- Observed evidence suggesting oligogenic inheritance in some early-onset, non-monogenic AD cases.
- Confirmed the role of amyloid-beta (Aβ) peptide aggregation as a core etiological factor in complex AD.
Conclusions:
- Research on monogenic AD provides relevant insights into complex AD mechanisms, particularly the amyloid cascade.
- Novel mechanistic insights and combined analysis of common/rare variants offer promising avenues for AD prevention.
- Future research holds potential for preventing early-onset AD and possibly later-onset forms.
More Related Videos
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.0K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
Related Concept Videos
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Human Genetics
572
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
572
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
